AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
-18.46%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$2.25B
AUM Growth
+$358M
(+19%)
Cap. Flow
+$718M
Cap. Flow
% of AUM
31.88%
Top 10 Holdings %
Top 10 Hldgs %
65.2%
Holding
325
New
76
Increased
82
Reduced
69
Closed
78
Top Buys
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$226M |
| 2 |
Apple
AAPL
|
$144M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
$112M |
| 4 |
Royal Caribbean
RCL
|
$65.3M |
| 5 |
Carnival Corp
CCL
|
$58.1M |
Top Sells
| 1 |
Check Point Software Technologies
CHKP
|
$50.1M |
| 2 |
SODA
SodaStream International Ltd
SODA
|
$21.3M |
| 3 |
Progressive
PGR
|
$2.18M |
| 4 |
Procter & Gamble
PG
|
$2.16M |
| 5 |
American Electric Power
AEP
|
$2.12M |
Sector Composition
| 1 | Technology | 27.25% |
| 2 | Consumer Discretionary | 14.81% |
| 3 | Industrials | 12.32% |
| 4 | Communication Services | 8.35% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Abbott
ABT
$231B
| $8K | ﹤0.01% |
+114
| New | +$8K |
|
177
Amgen
AMGN
$153B
| $8K | ﹤0.01% |
+41
| New | +$8K |
|
178
AtriCure
ATRC
$1.76B
| $8K | ﹤0.01% |
254
+49
| +24% | +$1.54K |
|
179
Bruker
BRKR
$4.68B
| $8K | ﹤0.01% |
+255
| New | +$8K |
|
180
Boston Scientific
BSX
$159B
| $8K | ﹤0.01% |
+222
| New | +$8K |
|
181
Calix
CALX
$3.96B
| $8K | ﹤0.01% |
+836
| New | +$8K |
|
182
Cadence Design Systems
CDNS
$95.6B
| $8K | ﹤0.01% |
+185
| New | +$8K |
|
183
DexCom
DXCM
$31.6B
| $8K | ﹤0.01% |
252
+56
| +29% | +$1.78K |
|
184
Edwards Lifesciences
EW
$47.5B
| $8K | ﹤0.01% |
+150
| New | +$8K |
|
185
F5
FFIV
$18.1B
| $8K | ﹤0.01% |
48
+11
| +30% | +$1.83K |
|
186
Fair Isaac
FICO
$36.8B
| $8K | ﹤0.01% |
43
+13
| +43% | +$2.42K |
|
187
Garmin
GRMN
$45.7B
| $8K | ﹤0.01% |
+125
| New | +$8K |
|
188
Haemonetics
HAE
$2.62B
| $8K | ﹤0.01% |
78
+15
| +24% | +$1.54K |
|
189
IAC Inc
IAC
$2.98B
| $8K | ﹤0.01% |
+246
| New | +$8K |
|
190
Intuit
INTU
$188B
| $8K | ﹤0.01% |
39
+7
| +22% | +$1.44K |
|
191
iRadimed
IRMD
$916M
| $8K | ﹤0.01% |
+315
| New | +$8K |
|
192
Jack Henry & Associates
JKHY
$11.8B
| $8K | ﹤0.01% |
60
+16
| +36% | +$2.13K |
|
|
JNPR
193
DELISTED
Juniper Networks
JNPR
| $8K | ﹤0.01% |
+287
| New | +$8K |
|
194
Eli Lilly
LLY
$652B
| $8K | ﹤0.01% |
70
+3
| +4% | +$343 |
|
195
Masimo
MASI
$8B
| $8K | ﹤0.01% |
76
+17
| +29% | +$1.79K |
|
196
Medtronic
MDT
$119B
| $8K | ﹤0.01% |
+85
| New | +$8K |
|
197
Merck
MRK
$212B
| $8K | ﹤0.01% |
109
+3
| +3% | +$220 |
|
198
Microsoft
MSFT
$3.68T
| $8K | ﹤0.01% |
+75
| New | +$8K |
|
199
Paychex
PAYX
$48.7B
| $8K | ﹤0.01% |
+118
| New | +$8K |
|
200
Regeneron Pharmaceuticals
REGN
$60.8B
| $8K | ﹤0.01% |
+21
| New | +$8K |
|